Pure Financial Advisors, LLC Amgen Inc Transaction History

Pure Financial Advisors, LLC

$4.25 Billion
Q4 2024

A detailed history of Pure Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pure Financial Advisors, LLC holds 3,503 shares of AMGN stock, worth $1.08 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,503

Previous 3,361 4.22%

Holding current value

$1.08 Million

Previous $1.08 Million 15.62%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$258.78 - $328.31 $36,746 - $46,620	142 Added 4.22%	3,503 $913,000
Q3 2024 Oct 29, 2024	SELL	$309.38 - $337.38 $7,734 - $8,434	-25 Reduced 0.74%	3,361 $1.08 Million
Q2 2024 Jul 18, 2024	BUY	$262.75 - $319.31 $142,936 - $173,704	544 Added 19.14%	3,386 $1.06 Million
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $65,873 - $79,517	245 Added 9.43%	2,842 $808,000
Q4 2023 Jan 08, 2024	BUY	$255.7 - $288.46 $27,104 - $30,576	106 Added 4.26%	2,597 $747,000
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $96,643 - $119,985	442 Added 21.57%	2,491 $669,000
Q2 2023 Jul 10, 2023	BUY	$214.27 - $253.37 $4,713 - $5,574	22 Added 1.09%	2,049 $454,000
Q1 2023 Apr 11, 2023	BUY	$225.79 - $275.2 $16,708 - $20,364	74 Added 3.79%	2,027 $490,000
Q4 2022 Jan 09, 2023	BUY	$229.03 - $291.01 $14,428 - $18,333	63 Added 3.33%	1,953 $0
Q3 2022 Oct 06, 2022	BUY	$224.46 - $253.15 $11,223 - $12,657	50 Added 2.72%	1,890 $426,000
Q2 2022 Jul 08, 2022	BUY	$230.71 - $256.74 $48,449 - $53,915	210 Added 12.88%	1,840 $448,000
Q1 2022 Apr 12, 2022	SELL	$219.27 - $242.57 $50,651 - $56,033	-231 Reduced 12.41%	1,630 $394,000
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $25,854 - $29,588	130 Added 7.51%	1,861 $419,000
Q3 2021 Oct 07, 2021	BUY	$212.27 - $248.7 $2,547 - $2,984	12 Added 0.7%	1,731 $368,000
Q2 2021 Jul 09, 2021	BUY	$233.58 - $259.14 $3,036 - $3,368	13 Added 0.76%	1,719 $419,000
Q1 2021 Apr 09, 2021	BUY	$221.91 - $258.6 $52,592 - $61,288	237 Added 16.13%	1,706 $424,000
Q2 2020 Jul 08, 2020	BUY	$197.81 - $242.74 $7,912 - $9,709	40 Added 2.8%	1,469 $346,000
Q1 2020 Apr 07, 2020	BUY	$182.24 - $241.7 $36,448 - $48,340	200 Added 16.27%	1,429 $290,000
Q3 2019 Oct 09, 2019	SELL	$174.11 - $208.62 $15,147 - $18,149	-87 Reduced 6.61%	1,229 $238,000
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $42,175 - $49,438	-253 Reduced 16.12%	1,316 $243,000
Q1 2019 Apr 05, 2019	BUY	$180.87 - $203.88 $24,779 - $27,931	137 Added 9.57%	1,569 $298,000
Q4 2018 Jan 11, 2019	BUY	$178.4 - $208.25 $20,694 - $24,157	116 Added 8.81%	1,432 $279,000
Q3 2018 Oct 04, 2018	SELL	$185.29 - $208.89 $59,292 - $66,844	-320 Reduced 19.56%	1,316 $273,000
Q2 2018 Jul 10, 2018	BUY	$166.05 - $186.51 $271,657 - $305,130	1,636 New	1,636 $302,000

Others Institutions Holding AMGN

# of Institutions

3,087

Shares Held

402M

Call Options Held

7.57M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pure Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pure Financial Advisors, LLC with notifications on news.

Account

Pure Financial Advisors, LLC Amgen Inc Transaction History